Avalo Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
27 Jun 23 | SellUS$2,500,930 | Armistice Capital LLC | Company | 18,396.06 | US$147.00 | |
27 Jun 23 | SellUS$2,168,897 | Armistice Capital LLC | Company | 15,348.21 | US$147.00 | |
26 Jun 23 | SellUS$1,030,179 | Cambyz Golestaneh | Individual | 6,700.05 | US$154.39 | |
20 Jun 23 | BuyUS$8,289 | Cambyz Golestaneh | Individual | 8.33 | US$994.65 | |
16 Jun 23 | BuyUS$23,355 | Cambyz Golestaneh | Individual | 25.67 | US$937.14 | |
14 Jun 23 | BuyUS$20,874 | Cambyz Golestaneh | Individual | 25 | US$834.95 | |
13 Jun 23 | BuyUS$42,755 | Cambyz Golestaneh | Individual | 45.41 | US$1,040.44 | |
09 Jun 23 | BuyUS$56,440 | Cambyz Golestaneh | Individual | 60.11 | US$994.24 | |
09 Jun 23 | BuyUS$13,680 | Garry Neil | Individual | 16.67 | US$820.79 | |
09 Jun 23 | BuyUS$1,748 | Christopher Sullivan | Individual | 2.13 | US$820.79 | |
31 May 23 | BuyUS$2,422 | Cambyz Golestaneh | Individual | 3.52 | US$688.79 | |
30 May 23 | BuyUS$7,464 | Cambyz Golestaneh | Individual | 11.13 | US$688.07 | |
24 May 23 | BuyUS$26,816 | Cambyz Golestaneh | Individual | 37.5 | US$721.72 | |
22 May 23 | BuyUS$89,372 | Cambyz Golestaneh | Individual | 110.92 | US$843.76 | |
16 May 23 | BuyUS$11,007 | Cambyz Golestaneh | Individual | 18.25 | US$659.99 | |
08 May 23 | BuyUS$69,364 | Cambyz Golestaneh | Individual | 104.17 | US$689.99 | |
27 Apr 23 | BuyUS$22,423 | Cambyz Golestaneh | Individual | 31.25 | US$719.83 | |
24 Apr 23 | BuyUS$53,671 | Cambyz Golestaneh | Individual | 72.92 | US$738.79 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 209 | 0.0202% |
Private Companies | 1,766 | 0.171% |
Institutions | 64,617 | 6.25% |
VC/PE Firms | 112,834 | 10.9% |
General Public | 854,704 | 82.6% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1780.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
112,834 | US$1.4m | 0% | 0.05% | |||
42,100 | US$514.0k | 0% | 0.05% | |||
15,876 | US$193.8k | 3,540% | no data | |||
4,604 | US$56.2k | 0% | no data | |||
1,766 | US$21.6k | 753% | no data | |||
556 | US$6.8k | 0% | no data | |||
522 | US$6.4k | 0% | 0.01% | |||
382 | US$4.7k | 0% | no data | |||
338 | US$4.1k | 0% | no data | |||
143 | US$1.7k | 0% | no data | |||
138 | US$1.7k | 13,700% | no data | |||
60 | US$732.4 | 9.09% | no data | |||
44 | US$536.6 | 2.33% | no data | |||
34 | US$415.4 | 0% | no data | |||
7 | US$85.9 | 600% | no data | |||
6 | US$73.2 | 20% | no data | |||
6 | US$73.2 | 0% | no data | |||
2 | US$24.0 | 100% | no data | |||
2 | US$24.0 | 0% | no data | |||
2 | US$24.0 | 100% | no data | |||
1 | US$12.6 | 0% | no data | |||
1 | US$12.6 | 0% | no data | |||
1 | US$12.6 | -75% | no data | |||
1 | US$12.6 | 0% | no data |